Vertebrate in vivo models using aquatic species will enhance detection of potential health hazards associated with toxic waste sites since spread of contaminants may occur as ground water leachates, particulate emissions and surface water runoff. The overall objective of this research is to integrate conventional aquatic toxicity approaches with state of the art methodologies to establish biomarkers of response to toxic components of complex waste mixtures. Assays will include endpoints of mutagenicity, carcinogenicity, and developmental toxicity. Fish are proven environmental sentinels and studies in this laboratory have established the medaka (Oryzias latipes), a small aquarium teleost fish, as an in vivo model for first screening toxicity of chemical- contaminant mixtures isolated from soil, water and air at toxic waste sites. Economy, speed, and adaptability to fresh, brackish and near shore marine salinities enable modeling of site-specific conditions. Being small, medaka permit histopathologic sampling of all target organs at once and increase statistical precision through use of large numbers, and enable thorough sampling for stereologic assessment. This model is particularly well adapted for a toxicity-based approach to characterization of sites, prioritization of locales within a site, monitoring of bioremediation, and identification of toxic compounds. Use of specific life stages further characterizes host response; the transparent chorion enables noninvasive assessment of developmental processes, dechorionation ensures accurate timing of exposure and sensitivity, hatchling acute toxicity tests are first and detect effects of exposure on normal and abnormal (tumorigenesis) growth. To achieve the overall goal, 4 specific aims are proposed: 1) determine genotoxicity including hepatocarcinogenicity of specific sediment extracts from estuarine and coastal habitats, particularly those near military bases in California; 2) conduct toxicity assays on complex mixtures and, on toxic fractions, use rapid IAA followed by HPLC and GLC MS to identify toxic components; 3) use the medaka cDNA library, prepared in a phagemid, to screen for specific oncogene (ras) and suppressor gene (p53) mutations as well as for up and/or down regulations of specific enzymes which are indicators of response to toxic compounds; and 4) transfer technology obtained from superfund basic research to county, state and federal employees providing them with the tools and skills needed to self monitor specific sites.

Project Start
Project End
Budget Start
Budget End
Support Year
10
Fiscal Year
1996
Total Cost
Indirect Cost
Mao, Yuxin; Pan, Yang; Li, Xuan et al. (2018) High-precision digital droplet pipetting enabled by a plug-and-play microfluidic pipetting chip. Lab Chip 18:2720-2729
Burmistrov, Vladimir; Morisseau, Christophe; Harris, Todd R et al. (2018) Effects of adamantane alterations on soluble epoxide hydrolase inhibition potency, physical properties and metabolic stability. Bioorg Chem 76:510-527
Stamou, Marianna; Grodzki, Ana Cristina; van Oostrum, Marc et al. (2018) Fc gamma receptors are expressed in the developing rat brain and activate downstream signaling molecules upon cross-linking with immune complex. J Neuroinflammation 15:7
Huo, Jingqian; Li, Zhenfeng; Wan, Debin et al. (2018) Development of a Highly Sensitive Direct Competitive Fluorescence Enzyme Immunoassay Based on a Nanobody-Alkaline Phosphatase Fusion Protein for Detection of 3-Phenoxybenzoic Acid in Urine. J Agric Food Chem 66:11284-11290
Zamuruyev, Konstantin O; Borras, Eva; Pettit, Dayna R et al. (2018) Effect of temperature control on the metabolite content in exhaled breath condensate. Anal Chim Acta 1006:49-60
Zamuruyev, Konstantin O; Schmidt, Alexander J; Borras, Eva et al. (2018) Power-efficient self-cleaning hydrophilic condenser surface for portable exhaled breath condensate (EBC) metabolomic sampling. J Breath Res 12:036020
Philippat, Claire; Barkoski, Jacqueline; Tancredi, Daniel J et al. (2018) Prenatal exposure to organophosphate pesticides and risk of autism spectrum disorders and other non-typical development at 3 years in a high-risk cohort. Int J Hyg Environ Health 221:548-555
Burmistrov, Vladimir; Morisseau, Christophe; Pitushkin, Dmitry et al. (2018) Adamantyl thioureas as soluble epoxide hydrolase inhibitors. Bioorg Med Chem Lett 28:2302-2313
Wang, Weicang; Yang, Jun; Zhang, Jianan et al. (2018) Lipidomic profiling reveals soluble epoxide hydrolase as a therapeutic target of obesity-induced colonic inflammation. Proc Natl Acad Sci U S A 115:5283-5288
Tu, Ranran; Armstrong, Jillian; Lee, Kin Sing Stephen et al. (2018) Soluble epoxide hydrolase inhibition decreases reperfusion injury after focal cerebral ischemia. Sci Rep 8:5279

Showing the most recent 10 out of 1149 publications